STOCK TITAN

USANA Health Sciences (USNA) director turns 1,058 RSUs into shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

USANA Health Sciences director Nixon J. Scott reported an equity award transaction. On January 22, 2026, 1,058 restricted stock units (RSUs) were converted into 1,058 shares of USANA common stock at an exercise price of $0.00 per share, reflecting the nature of RSUs as stock-based compensation rather than a cash purchase.

After this transaction, Scott directly owned 8,756 shares of USANA common stock and 1,057 RSUs. The RSUs vest in four equal 25% installments on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026, each representing the right to receive one share of USANA common stock when vested.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nixon J Scott

(Last) (First) (Middle)
3838 WEST PARKWAY BLVD.

(Street)
SALT LAKE CITY UT 84120

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/22/2026 M 1,058 A (1) 8,756 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 01/22/2026 M 1,058 (2) (2) Common Stock 1,058 $0 1,057 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact 01/26/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did USANA (USNA) director Nixon J. Scott report?

Nixon J. Scott reported the conversion of 1,058 restricted stock units into 1,058 shares of USANA common stock on January 22, 2026, at an exercise price of $0.00 per share.

How many USANA common shares does Nixon J. Scott own after this Form 4 transaction?

Following the reported transaction, Nixon J. Scott directly owned 8,756 shares of USANA common stock, as disclosed in the filing.

What happens to the restricted stock units (RSUs) reported by Nixon J. Scott?

Each restricted stock unit represents a contingent right to receive one share of USANA common stock. When RSUs vest, they convert into common shares, as shown by the 1,058 RSUs turning into 1,058 shares.

What RSU vesting schedule is disclosed for Nixon J. Scott’s USANA awards?

The RSUs vest 25% on July 24, 2025, 25% on October 23, 2025, 25% on January 22, 2026, and 25% on April 23, 2026, according to the filing.

How many restricted stock units does Nixon J. Scott hold after the January 22, 2026 transaction?

After the reported RSU conversion, Nixon J. Scott directly held 1,057 restricted stock units, in addition to his common stock holdings.

Is this USANA Form 4 transaction a stock purchase or compensation event?

The transaction reflects an equity compensation event, where RSUs were converted into common shares at $0.00 per share, consistent with stock-based compensation rather than an open-market stock purchase.

Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

411.87M
10.42M
42.93%
61.22%
3.86%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY